Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

About the company

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

29

$NoneM

Total Revenue

29

Employees

$1B

Market Capitalization

-18.93

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382409.47 82729.00 6.14 22.29 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 153076.50 23087.00 51.95 26.98 23.97
AbbVie, Inc. ABBV 147435.40 34057.00 -23.60 17.58 24.65
Bristol Myers Squibb Co. BMY 113009.51 31006.00 2.74 96.08 3.08
Repligen Corp. RGEN 6331.14 286.00 6.07 275.87 8.11
Reata Pharmaceuticals, Inc. RETA 4824.84 20.00 22.85 -15.52 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3748.16 1.00 34.65 -5.73 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2261.52 None 6.81 -18.92 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1639.59 None 5.33 -26.30 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1590.96 30.00 5.67 -22.64 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1360.91 341.00 2.79 -48.38 -8.59
Tricida, Inc. TCDA 1310.26 None 6.74 -6.20 None
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Arcutis Biotherapeutics, Inc. ARQT 1184.00 None 5.05 -18.93 None
Odonate Therapeutics, Inc. ODT 1121.14 None 9.18 -9.96 None
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Phathom Pharmaceuticals, Inc. PHAT 794.00 None 4.40 -2.92 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Quanterix Corp. QTRX 732.51 60.00 6.46 -16.75 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Aprea Therapeutics, Inc. APRE 714.00 None 6.32 -21.12 None
Applied Therapeutics, Inc. APLT 712.58 14.00 4.60 -14.46 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Arcturus Therapeutics Holdings, Inc. ARCT 645.58 19.00 59.83 -23.21 -151.34
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Oyster Point Pharma, Inc. OYST 554.61 None 5.57 -9.64 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
Biospecifics Technologies Corp. BSTC 466.97 40.00 3.79 19.97 61.80
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Kala Pharmaceuticals, Inc. KALA 391.56 6.00 4.28 -4.27 None
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Relmada Therapeutics, Inc. RLMD 373.32 0.00 5.57 -31.19 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 300.30 4.00 9.48 -3.74 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Spero Therapeutics, Inc. SPRO 260.49 12.00 3.43 -3.20 -656.72
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Lannett Co., Inc. LCI 252.32 542.00 0.86 -8.30 -5.77
Gritstone Oncology, Inc. GRTS 227.88 4.00 2.04 -2.18 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 219.60 12.00 2.43 -6.78 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
Sutro Biopharma, Inc. STRO 184.92 41.00 3.51 -3.03 -148.06
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Protara Therapeutics, Inc. TARA 173.70 None 2.61 -11.26 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 138.32 119.00 3.53 -4.41 -27.05
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
PhaseBio Pharmaceuticals, Inc. PHAS 126.73 2.00 2.35 -2.65 None
NeuBase Therapeutics, Inc. NBSE 123.62 None 51.94 -2.77 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
EyePoint Pharmaceuticals, Inc. EYPT 79.57 26.00 5.62 -1.62 -196.30
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Baudax Bio, Inc. BXRX 67.32 None -1.83 -0.96 None
Navidea Biopharmaceuticals, Inc. NAVB 67.15 1.00 -49.38 -6.08 -65.13
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 50.17 2.00 4.22 -0.54 -483.51
Annovis Bio, Inc. ANVS 47.46 None 4.35 -37.67 None
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Oncternal Therapeutics, Inc. ONCT 32.50 3.00 4.17 -1.29 -225.89
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.30 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Titan Pharmaceuticals, Inc. TTNP 11.84 4.00 4.93 -0.66 -437.91
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Arcutis Biotherapeutics Inc.

6d ago, source: MarketWatch

Inc. and Arcutis Biotherapeutics, Inc. He previously was Consultant at McKinsey & Co., Inc., Research Assistant at Stanford University and Researcher at the University of Michigan. Dr. Estes ...

Inogen Inc (INGN): Are Hedge Funds Right About This Stock?

2d ago, source: YAHOO!

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they ...

Is Arcutis Biotherapeutics, Inc. (ARQT) Going to Burn These Hedge Funds?

15d ago, source: YAHOO!

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shareholders have witnessed an increase in enthusiasm from smart money lately. ARQT was in 8 hedge funds' portfolios at the end of the first quarter of ...

BRIEF-Arcutis Enrolls Last Patient In Phase 2 Proof Of Concept Clinical Trial Evaluating Arq-154

15d ago, source: Reuters

ARCUTIS ENROLLS LAST PATIENT IN PHASE 2 PROOF OF CONCEPT CLINICAL TRIAL EVALUATING ARQ-154 (TOPICAL ROFLUMILAST FOAM) AS A POTENTIAL TREATMENT FOR SEBORRHEIC DERMATITIS * ARCUTIS BIOTHERAPEUTICS INC - ...

MyoKardia's Positive Data And Other News: The Good, Bad And Ugly Of Biopharma

Opinion ago, source: Seeking Alpha

MyoKardia's danicamtiv trial yields positive results. Ziopharm completes enrolment for trial of Ad-RTS-hIL-12 with veledimex in combination with Regeneron' Libt ...

Arcutis to Present at the Goldman Sachs 41st Annual Global Health Care Conference

27d ago, source: Business Insider

June 10, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in ...

Arcutis Biotherapeutics Inc.

29d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.